Esomeprazole Magnesium For Suspension
Product Images NDC 69097-529

9 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 69097-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 01)

Figure-1 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 01)
Chemical structure of esomeprazole magnesium shown as a detailed molecular diagram including magnesium ion and hydration state (2 H2O). The structure visually represents the molecular formula of the active ingredient esomeprazole magnesium in the drug.*
FDA Label Image

Figure 2 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 02)

Figure 2 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 02)
A line graph depicting the percent of patients maintaining response over a six-month period for Esomeprazole magnesium suspension at 10 mg, 20 mg, and 40 mg doses compared to placebo. The x-axis represents months, and the y-axis shows the percent maintained. Higher doses generally sustain higher percentages over time.*
FDA Label Image

Figure 3 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 03)

Figure 3 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 03)
A line graph showing percent maintained over a 6-month period for different doses of esomeprazole magnesium (10 mg, 20 mg, 40 mg) and placebo. The y-axis represents percent maintained, and the x-axis represents months. The 40 mg and 20 mg doses maintain close to 100% over time, while 10 mg and placebo show a decline.*
FDA Label Image

Figure-4 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 04)

Figure-4 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 04)
A line graph depicting the percent of patients symptom-free over a 28-day diary period, comparing Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent symptom-free ranging from 0 to 100%. Data shows symptom-free percentage trends over time for each treatment.*
FDA Label Image

Figure-5 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 05)

Figure-5 (Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 05)
A line graph showing the percentage of patients symptom-free over 28 diary days, comparing Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The y-axis represents percent symptom-free patients, while the x-axis measures diary days from 0 to 28. Three lines depict outcomes for the 40 mg dose, 20 mg dose, and placebo.*
FDA Label Image

20mg-sachet-label (20mg Sachet Label)

20mg-sachet-label (20mg Sachet Label)
Esomeprazole magnesium 20 mg/1 oral suspension label from Cipla USA Inc. The label includes dosage strength and form, directions to open, NDC number, and manufacturer information. It is a prescription drug label for delayed-release oral suspension.*
FDA Label Image

20mg-carton-label (20mg Catron Label)

20mg-carton-label (20mg Catron Label)
Packaging label for Esomeprazole Magnesium 20 mg for Delayed-Release Oral Suspension by Cipla USA Inc. The label states each carton contains 30 child-resistant packets, with dosing information and storage instructions. It includes the NDC 69097-528-34 and a barcode, with manufacturer details and a note for pharmacist medication guide dispensing.*
FDA Label Image

40mg-sachet-label (40mg Sachet Label)

40mg-sachet-label (40mg Sachet Label)
Label for Esomeprazole magnesium delayed-release oral suspension, 40 mg strength, by Cipla USA Inc. The label displays the proprietary and generic names, dosage form for suspension, strength 40 mg, and includes usage instructions and ingredients. It also contains barcode, NDC numbers, lot number, and expiration date.*
FDA Label Image

40mg-carton-label (40mg Carton Label)

40mg-carton-label (40mg Carton Label)
Esomeprazole Magnesium 40 mg for Delayed-Release Oral Suspension carton label from Cipla USA Inc. The label indicates 30 child-resistant packets, each containing 43.376 mg of Esomeprazole Magnesium Dihydrate USP equivalent to 40 mg esomeprazole. The packaging specifies pharmacist dispensing instructions and storage conditions, with the NDC 69097-529-34 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.